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Objective: To investigate the magnitude of change at differ-
ent time points in measures of gait symmetry, gait velocity 
and self-reported function following total hip replacement. 
Design: Longitudinal with test occasions pre-surgery and 3, 
6 and 12 months post-surgery.
Subjects: Thirty-four patients with hip osteoarthritis (mean 
age 63 years, standard deviation 11 years).
Methods: Subjects walked back and forth along a 7-m walk-
way at slow, preferred and fast speed. Anteroposterior, 
vertical and mediolateral trunk symmetry was assessed by 
accelerometry, while single support symmetry, step-length 
symmetry and gait velocity was simultaneously assessed by 
an electronic walkway. Self-reported function was assessed 
by Hip disability and Osteoarthritis Outcome Score. Gait 
symmetry data were normalized for gait velocity. Changes 
between test occasions were reported as effect size.
Results: All measures showed effect sizes > 0.30 from pre-
operative to 12-months postoperative assessments, and im-
provements were significant (p < 0.05) in all measures, except 
medio lateral symmetry. In general, gait symmetry and gait 
velocity improved most 6 and 12 months postoperatively, 
while self-reported function improved most 3 months post-
operatively. 
Conclusion: Early improvements were seen in self-reported 
function, suggesting immediate relief from stiffness and 
pain, while gait symmetry and velocity improved later post-
operatively, suggesting that gait quality and performance re-
quire prolonged rehabilitation with postoperative guidance, 
muscular strengthening and motor relearning. 
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INTRODUCTION
Gait symmetry is often a goal for physiotherapy in patients 
after total hip replacement (THR), and has been advocated 
when evaluating gait quality after disease or injury affect-
ing the lower limbs, such as stroke and hip osteoarthritis (1, 
2). However, gait symmetry is not routinely assessed as a 
clinical outcome following THR. Evaluation should include 
temporal and spatial footfall movement as well as measures 
of trunk movement (1), because compensatory movements 
of the upper body are frequently seen in patients with injury 
or disease in the hip (3, 4). At present, gait velocity and self-
reported function are typically reported as clinical outcomes 
after THR (5–7). These measures are easily administrated. 
Gait velocity is considered a fundamental measure of gait 
(3), while self-reported function has been advocated as a 
supplement to other information on clinical outcome (8). In 
contrast to measures of gait symmetry, gait velocity and self-
reported function do not provide information that relate easily 
to specific movement strategies, which may in turn provide 
valuable information for the development of individually 
targeted rehabilitation programmes. Most longitudinal studies 
on change in function following THR assess function only 
once before and after surgery. Thus, information regarding 
the magnitude of change in function at different points in 
time is not known. Better knowledge about functional change 
following surgery may lead to better targeted rehabilitation 
programmes. The purpose of this study was to investigate 
the magnitude of change of gait symmetry, gait velocity and 
self-reported function at different time-points during the first 
12 months after THR. 
MATERIAL AND METHODS
Subjects
A total of 41 patients with primary hip osteoarthritis scheduled for 
hip replacement surgery were recruited from two university hospitals. 
To reflect the population in need of THR, chosen inclusion criteria 
comprised both genders at a wide range of ages (Table I), 3 categories 
of hip involvement (Table II), different implants and 2 postoperative 
weight-bearing regimes (Table II). However, all patients were without 
other musculoskeletal ailments likely to influence walking ability and 
were able to walk at least 10 m without assistive devices at all test 
occasions. For inclusion in the final analysis, subjects had to comply 
with postoperative instructions from the 2 operating hospitals and at-
tend at least 3 test occasions. In order to compare outcome measures 
at a common gait velocity of 0.9 m/s, included patients had to have 
this speed within the range of self-selected gait velocities at every test 
occasion. Thirty-four patients with a mean age of 63 years, standard 
deviation (SD) 11 years (Table I) were included in the final analyses, 
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symptoms equal a score of 0, while 100 indicates extreme symptoms, 
according to the HOOS LK 1.1 User’s Guide 2003 (18). 
Procedure
To become accustomed to the equipment and avoid practice effect, 
subjects walked across the walkway twice before data collection 
started. Each subject then walked 6 times along the 7-m walkway: 2 
walks at self-selected slow speed, 2 walks at self-selected preferred 
speed, and 2 walks at self-selected maximum safe speed. Footfall 
and trunk symmetry measures were assessed during the middle 4.3 m 
of the walkway, leaving the rest of the walkway for acceleration and 
deceleration. The subjects wore their own shoes and performed the 
tests without any personal assistance or walking aids. Questionnaires 
were posted to each subject less than 1 week before test occasions and 
returned when subjects presented for testing.
Data analysis
The electronic walkway’s software (GAITRite3A) and Microsoft Excel 
(97-2003) were used in the calculations of footfall measures and gait 
velocity. Analogue signals from the accelerometer were low-pass 
filtered at 55 Hz and sampled at 128 Hz before digital signals were 
transferred to a laptop for off-line processing in Matlab 7.1 (The Math-
works Inc., Natick, MA, USA). Acceleration signals were transformed 
to a true horizontal–vertical coordinate system, keeping the AP axis in 
the sagittal plane to eliminate unwanted gravity components caused 
by inaccurate orientation of the sensor (19). 
after the exclusion of one patient due to postponed THR surgery, 2 due 
to postoperative complications, 2 because they missed 2 test occasions, 
and 2 because they walked too slowly 3 months postoperatively. All 
subjects received postoperative physical therapy during the hospital 
stay, and were encouraged to avoid the extremes of hip rotation, flexion 
and adduction. The Regional Committee for Medical Research Ethics 
approved the study, and all participants provided informed consent.
Measurements
Single support (% of stride time), step length (m), and gait velocity 
(m/s) were registered by an electronic walkway (GAITRite Gold, CIR 
Systems Inc., NJ, USA). The GAITRite® has previously showed good 
to excellent test–retest reliability of temporal–spatial gait parameters 
(9–12), and is regarded as a valid tool for assessment of those para-
meters (9, 10). Trunk acceleration in anteroposterior (AP), vertical (V) 
and mediolateral (ML) directions was simultaneously registered by 
a 0.015 kg triaxial, piezoresistant accelerometer (Logger technology 
HB, Malmö, Sweden), which provides reliable and valid measures of 
movement during gait (13, 14). A computerized stopwatch was syn-
chronized to the accelerometer and registered time sequences for each 
walk through photoelectric cells. The accelerometer was secured to the 
subject’s back, approximately at the L3-level of the spine, by a custom-
ized belt, and connected to a 0.3 kg battery-operated Personal Compu-
ter Memory Card International Association card data-logger (Logger 
Technology HB, Malmö, Sweden), also worn by the subjects. 
The Hip disability and Osteoarthritis Outcome Score questionnaire 
(HOOS), Likert version (LK) 1.1, was used to assess self-reported 
symptoms and functional limitations. HOOS is disease specific and 
was developed to evaluate self-reported problems of patients with hip 
osteoarthritis (15, 16). HOOS has adequate measurement properties of 
validity and reliability (17), and has been recommended for use in the 
evaluation of patients with hip osteoarthritis before and after total hip 
replacement (16). The questionnaire is scored according to the “HOOS 
LK 1.1 User’s Guide 2003” (18) with 39 items in 5 sub-scales:
• P = Pain;
• S = Other symptoms, including stiffness;
• ADL = Function in daily living;
• QOL = Hip-related quality of life;
• SP = Function in sport and recreation.
Data from the SP subscale was not registered at postoperative tests 
due to postoperative movement restrictions. In each subscale, no 
Table I. Descriptive characteristics of the patients preoperatively (pre) 
and 3, 6, and 12 months postoperatively (post 3, 6, and 12)












sample, years 63 (10.8)
Age, men, years 
(n = 14) 60 (12.6)
Age, women, 
years (n = 20) 65 (9.3)
Height, m 1.74 (0.09) 1.74 (0.09) 1.74 (0.09) 1.74 (0.09)
Weight, kg 83.3* (16.4) 83.4 (15.7) 83.9 (15.9) 86.3 (14.6)
BMIb, kg/m2 27.6* (4.9) 27.5 (4.7) 27.8 (4.7) 28.5 (4.5)
Step countc 40 (9) 38 (7) 35 (5) 33 (6)
*Significant difference between preoperative and 12 months postoperative 
assessments (p = 0.05).
aMissing data not imputed for descriptive characteristics.
bIndoor clothing, shoes and equipment (body fixed sensor and data logger) 
included in the measures of height and weight. 
cThe total number of steps used to calculate outcome measures at each 
test occasion.
BMI: body mass index; SD: standard deviation.
Table II. Diagnostic, operational and postoperative weigth-bearing 











Left hip 6 (18) 9 (26) 15 (44)
Right hip 9 (26) 10 (29) 19 (56)
Total 15 (44) 19 (56) 34 (100)
Diagnostic group (radiographic 
images)
1-sided osteoarthritis 5 (15) 11 (32) 16 (47)
2-sided osteoarthritis 1st hip to be 
operated
4 (12) 5 (15) 9 (26)
2-sided osteoarthritis 2nd hip to be 
operated
6 (18) 3 (9) 9 (26)
Total 15 (44) 19 (56) 34 (100)
Prosthesis; acetabulum/
femur components
cCharnley Ogee cement/Charnley 
cement 
2 (6) 12 (35) 14 (41)
cReflection cement/Spectron cement 5 (15) 3 (9) 8 (24)
dReflection/Landos Corail cement 
less 
5 (15) 5 (15)
cOther brands 3 (9) 1 (3) 4 (12)
eBirmingham hip resurfacing 3 (9) 3 (9)
Total 15 (44) 19 (56) 34 (100)
aPWB: partial weight-bearing. Patients were instructed to allow a 
maximum load of 20–30 kg on the operated leg and to use crutches 3 
months post-operatively. Patients operated with direct lateral approach 
were additionally instructed to avoid active hip abduction exercises 6 
weeks post-operatively.
bWBAT: weight-bearing as tolerated, limited by pain. Patients were 
instructed to use crutches 6 weeks post-operatively.
cDirect lateral approach. 
dDirect lateral approach in 3 patients and dorsal approach in 1 patient. 
eDorsal approach.
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Between-step and between-stride trunk regularity were assessed 
by an autocorrelation procedure where a cyclic acceleration curve 
representing a walk was correlated to the same curve at a phase shift 
of one step and one stride, respectively. In the mathematical procedure 
proposed by Moe-Nilssen & Helbostad (20) and adopted by Tura et 
al. (21), the generic unbiased autocorrelation function, Ad(m), of the 
sample sequence x(i) is computed using:
where, N is the number of samples and m is the time lag expressed as 
number of samples. The first peak of Ad(m) represents between-step 
regularity, while the second peak of Ad(m) represents between-stride 
regularity. Regularity values approaching 1.0 imply highly repetitive 
gait or high gait regularity, while values approaching 0.0 imply low 
gait regularity. 
Scores were imputed for patients who missed one gait assessment. 
Changes in group mean values were calculated and added to the previ-
ous score of the patient with missing data. While the total number of 
score was 156 (4 test occasions times 34 patients) for each outcome 
measure, 8 of these scores were missing and thus imputed for each of 
SL and SS symmetry. For trunk symmetry and gait velocity measures, 
the number of imputed scores was 6 for each measure. 
Missing data within each subscale of the HOOS questionnaire were 
replaced by the mean value for the subscale in question, as reported in 
previous studies (15). If more than 2 items were missing, the subscale 
in question was deleted from the analysis. To evaluate the inclusion 
of missing values, Friedman’s analysis of variance (ANOVA) was 
performed with and without the imputed values. 
All gait symmetry measures were checked for speed dependency 
using data from the 6 walks performed by each subject preoperatively. 
The gradients (b1) of individual linear trend lines of a symmetry meas-
ure vs walking speed were tested by one-sample t-tests for H0: b1= 0. 
The tests returned significant linear relationships for most symmetry 
measures. Thus, controlling symmetry measures for gait velocity was 
warranted. Data from the 6 walks were used to make linear curve es-
timates for each subject, and data at a point estimate of 0.9 m/s were 
used in the analysis. This speed was within the range of gait velocities 
for included subjects at all test occasions, except for 1 patient whose 
fastest velocity 3 months postoperatively was 0.84 m/s. To avoid 
overall exclusion of this patient, linear curve estimates of symmetry 
data in relation to speed were extrapolated to 0.9 m/s at this particular 
occasion, before symmetry data were estimated. 
Symmetry indices (SI) were calculated for each trunk and footfall 
measure. Step length and single support symmetry ratio were used to 
describe footfall symmetry: 
SIfootfall = 1 – (limb with lower value/limb with higher value) 
Trunk measures are previously used to describe gait symmetry (1, 
20, 21), and symmetry indices were calculated separately for AP, V 
and ML signals:
SItrunk=between-stride regularity – │between-step regularity│
Absolute values of between-step trunk regularity are used because 
the software displays ML between-step trunk regularity with negative 
values. Ratio calculations of trunk measures are unsuitable because 
the between-step and between-stride autocorrelations may approach 
zero if regularity between neighbouring steps or neighbouring strides 
is low. The number zero cannot be used as the denominator. Hence, 
the symmetry indices of footfall and trunk measures are based on dif-
ferent calculations. However, at perfect symmetry, both indices equal 
0, and positive indices indicate asymmetric gait. 
Statistical analysis
Anthropometric data are presented as mean and SDs, while paired 
sample t-tests were used to evaluate change in these data from preop-
erative to 12 months postoperative assessments (Table I). The outcome 
measures, gait symmetry, gait velocity and self-reported function, are 
presented as median with 25th and 75th percentiles. Wilcoxon rank-sum 
test was used to assess possible differences in outcome measures re-
lated to differences in gender, postoperative weight-bearing restrictions 
or operating hospital. The Kruskal-Wallis test, followed by Wilcoxon 
rank-sum test when appropriate, was used to assess differences in 
outcome measures related to hip involvement. Change from preopera-
tive to 12 months postoperative assessment was evaluated with the 
Friedman’s ANOVA, while the Wilcoxon signed-rank was used to 
assess changes between neighbouring assessments. To correct for the 
number of tests in the Wilcoxon signed-rank analysis, the Bonferroni 
corrections (α/number of comparisons) was used to decide a critical 
values (22, p. 577). Effect size (ES) was used to quantify functional 
change, as it is suited to compare the magnitude of change in measures 
using different scales and units of measurements (23, 24). Reports were 
made between neighbouring test occasions, and between preoperative 
and 12 months postoperative tests. The Rosenthal (25) formula, also 
adopted by Field (22, p. 550); ES =          , lets Z equal the value of 
the observation expressed in SD units, while N is the number of total 
observations on which Z is based (22, p. 580). Small, medium and 
large magnitude of change equal ES values above respectively 0.1, 
0.3 or 0.5, as suggested by Cohen (26), who further suggests that 
medium effect is comparable to improvement visible to the eye (26). 
The level of significance was set at p < 0.05. Statistical analyses were 
performed in Microsoft Excel and Statistical Package for Social Sci-
ences (SPSS) Version 18. 
RESULTS
Patients increased their body weight significantly from pre-
operative to 12 months postoperative assessments (Table I). 
The mean number of steps used to evaluate gait symmetry 
was from 33 (SD 6) to 40 (SD 9) per test occasion (Table I). 
In general, men walked significantly faster than women at 
fast and preferred gait velocities throughout test occasions 
(p = 0.001 – p = 0.042), except for preferred gait velocity pre-
operatively, where the difference was insignificant (p = 0.10). 
Patients from one hospital showed higher gait symmetry, 
lower gait velocity and self-reported function. These dif-
ferences were insignificant at most test occasions, except 
in 3 HOOS subscales preoperatively; symptoms (p = 0.035), 
ADL (p < 0.001) and QOL (p = 0.046), AP symmetry 3 and 
12 months postoperatively (p = 0.04 – p = 0.03) and ML sym-
metry 6 months postoperatively (p = 0.02). Most outcome 
measures were unaffected by differences in postoperative 
weight-bearing restrictions, except for HQOL preoperatively 
(p = 0.045), V symmetry 3 months postoperatively (p = 0.007) 
and ADL 12 months postoperatively (p = 0.048). No differences 
in outcome measures were related to diagnostic group, except 
ADL 3 and 6 months postoperatively, where patients with 
one-sided affection demonstrated better self-reported function 
than patients with respectively bilateral 1st hip to be operated 
(p = 0.008) and bilateral 2nd hip to be operated (p = 0.011). All 
outcome measures, except ML symmetry, showed significant 
improvement from preoperative to 12 months postoperative 
assessments (Table III). 
The magnitude of change between preoperative and 12 
months postoperative assessments in symmetry measures that 
showed significant improvement ranged from ES 0.33 to 0.52 
(Table III). Comparing neighbouring test occasions, the larg-
est improvement in AP and SS gait symmetry was seen from 
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6 to 12 months postoperatively, while V showed the highest 
improvement between preoperative and 3 months postoperative 
assessments; however, continuous improvement (ES > 0.22) 
throughout test occasions.
In measures of gait velocity, the ES magnitude of change 
from preoperative to 12 months postoperatively ranged from 
0.42 to 0.54. Median gait velocity decreased insignificantly 
from preoperative to 3 months postoperatively, while the 
increase in gait velocity was largest from 3 to 6 months post-
operatively (Tables III and IV).
The magnitude of change from preoperative to 12 months 
postoperative test occasions in self-reported function ranged 
from ES 0.61 to 0.62. The largest improvement in self-reported 
function was seen from preoperative to 3 months postopera-
Table IV. Median values with 25th and 75th percentiles (percentiles) of symmetry indices, gait velocities and HOOS subcategories (n = 34) preoperatively 











AP 0.26 (0.10, 0.51) 0.15 (0.06, 0.47) 0.09 (0.06, 0.18) 0.09 (0.04, 0.14)
V 0.15 (0.05, 0.28) 0.06 (0.02, 0.18) 0.04 (0.01, 0.12) 0.03 (0.00, 0.09)
ML 0.13 (0.06, 0.28) 0.14 (0.05, 0.23) 0.12 (0.08, 0.19) 0.08 (0.03, 0.18)
SL 0.05 (0.03, 0.09) 0.04 (0.02, 0.07) 0.04 (0.03, 0.09) 0.04 (0.01, 0.06)
SS 0.08 (0.04, 0.13) 0.05 (0.03, 0.12) 0.04 (0.02, 0.07) 0.04 (0.01, 0.07)
Velocity (m/s)
Fast 1.50 (1.26, 1.83) 1.48 (1.28, 1.86) 1.57 (1.38, 1.96) 1.74 (1.42, 1.98)
Pref 0.97 (0.87, 1.13) 0.96 (0.87, 1.11) 1.08 (0.95, 1.21) 1.18 (1.05, 1.30)
Slow 0.49 (0.45, 0.59) 0.49 (0.43, 0.58) 0.54 (0.45, 0.68) 0.68 (0.62, 0.79)
HOOS
Pa 61.1 (52.8, 66.7) 13.9 (2.8, 27.8) 13.9 (5.6, 25.0) 5.6 (0, 19)
S 57.5 (43.8, 70.0) 25 (15, 35) 20 (10, 31.3) 15 (5, 20)
ADL 58.8 (48.9, 63.2) 29.4 (22.8, 35.3) 16.2 (8.1, 32.4) 10.3 (2.9, 21.3)
QOL 75 (67.2, 82.8) 50 (43.8, 62.5) 37.5 (25, 51.6) 37.5 (25, 50)
SPb 75 (68.8, 87.5)
an = 33; bSP only reported preoperatively, due to postoperative movement restrictions. 
Gait velocities: Fast, Preferred (pref) and Slow; AP: anteroposterior; V: vertical; ML: mediolateral; SL: step length; SS: single support; HOOS: Hip 
disability and Osteoarthritis Outcome Score questionnaire; P = Pain, S = Other symptoms, including stiffness; ADL: function in daily living; QOL: 
hip-related quality of life; SP: function in sport and recreation.
Table III. Friedman’s analysis of variance (ANOVA) (χ2) statistics of main effect with level of significance (p-value), post-hoc tests (Wilcoxon signed-
rank tests) with a Bonferroni correction of level of significance p < 0.0167 (0.05/3) are applied and supplemented with effect sizes (ES) to evaluate 
change between neighbouring assessments
Main effecta
p-value
Pre-post 12 Pre-post 3 Post 3–6 Post 6–12
p-value ESb p-value ESb p-value ESb p-value   ESb
Symmetry indices
AP < 0.001 < 0.001 –0.43 0.125 –0.19 < 0.001 –0.41 0.191 –0.16
V < 0.001 < 0.001 –0.52 0.013 –0.30 0.043 –0.25 0.064 –0.22
ML 0.20 0.11 –0.20 0.774 –0.04 0.661 –0.05 0.011 –0.31
SL 0.011 0.006 –0.33 0.030 –0.26 0.554 –0.07 0.015 –0.29
SS 0.002 < 0.001 –0.41 0.543 –0.08 0.012 –0.30 0.778 –0.04
Velocity, m/s
Fast < 0.001 < 0.001 –0.51 0.791 –0.03 < 0.001 –0.42 0.388 –0.11
Pref < 0.001 < 0.001 –0.54 0.598 –0.07 0.001 –0.40 0.001 –0.38
Slow < 0.001 < 0.001 –0.42 0.713 –0.05 0.073 –0.22 < 0.001 –0.45
HOOS
Pc < 0.001 < 0.001 –0.62 < 0.001 –0.61 0.319 –0.12 0.002 –0.35
S < 0.001 < 0.001 –0.62 < 0.001 –0.58 0.016 –0.29 < 0.001 –0.40
ADL < 0.001 < 0.001 –0.61 < 0.001 –0.59 < 0.001 –0.47 0.002 –0.36
QOL < 0.001 < 0.001 –0.62 < 0.001 –0.59 < 0.001 –0.45 0.34 –0.12
aMain effect based upon χ2 test (degrees of freedom = 3); bES based upon Z-values; cn = 33; 
ES values above 0.1, 0.3 or 0.5 represent small, medium and large effects. 
AP: anteroposterior; V: vertical; ML: mediolateral; SL: step length; SS: single support; Gait velocities: Fast, Preferred (pref) and Slow; HOOS: Hip 
disability and Osteoarthritis Outcome Score questionnaire; P: pain; S: other symptoms, including stiffness; ADL: function in daily living; QOL: hip-
related quality of live; SP: function in sport and recreation.   
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tively (Tables III and IV), although improvement was high for 
most categories throughout test occasions. 
DISCUSSION
The purpose of this study was to investigate the magnitude of 
change in measures of gait symmetry, gait velocity and self-
reported function preoperatively, and 3, 6 and 12 months postop-
erative to THR. A repeated measures design was chosen to allow 
identification of periods with larger and smaller magnitudes of 
clinical change. Overall, all measures showed postoperative 
improvement in function, but the period of largest change dif-
fered between measures. While gait symmetry and gait velocity 
measures in general showed the largest postoperative improve-
ment towards 6 and 12 months postoperatively (Fig. 1a, 1b), 
self-reported function showed the largest improvement towards 3 
months postoperatively. However, improvement in self-reported 
function was large for all test occasions (Fig. 1c). 
Fig. 1. (a–c) Median with 25th and 75th percentiles for outcome measures assessed preoperatively (pre), and 3, 6 and 12 months (post, 3, 6, 12) after total 
hip replacement surgery. (a) Anteroposterior (AP), vertical (V), mediolateral (ML) trunk symmetry indices, step length (SL) and single support (SS) 
symmetry indices (0 = perfect symmetry). (b) Fast, preferred and slow gait velocity. (c) Hip disability and Osteoarthritis Outcome Score questionnaire 
(HOOS) with subscales: Pain, Other symptoms, including stiffness, Function in daily living (ADL), and hip-related quality of life (QOL) (0–100 = best 
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The largest improvement in most symmetry measures was 
observed at test occasions 6 and 12 months postoperatively. 
The same time-lagged postoperative improvement in gait sym-
metry has also been reported previously (27, 28), and may be 
explained by early postoperative weight-bearing restrictions, 
time needed to recover from surgery and the need for muscular 
strengthening and motor relearning to achieve symmetrical 
gait. Change in ML symmetry differed somewhat compared 
with the other symmetry measures, and improvement was 
scarce at assessments 3 and 6 months postoperatively. How-
ever, 12 months postoperatively, ML symmetry showed largest 
improvement among symmetry measures, suggesting that ML 
symmetry describes different qualities of gait compared with 
other symmetry measures. Unilateral muscular weakness of the 
hip abductors has been reported in patients with osteoarthritis 
(27, 29) and has also been found to persist 2 years after THR 
(27). The weakness may lead to the so-called Trendelenburg 
gait, where a failure to stabilize the pelvis during stance may 
result in lateral deviation of the trunk, hence ML trunk asym-
metry. 
The pattern of change in gait velocity differed somewhat 
compared with the observed change in gait symmetry and 
self-reported function (Fig. 1c), as patients tended to walk 
slightly slower after 3 months than they did preoperatively. 
Thereafter, gait velocity increased at 6 and 12 months post-
operative assessments. The delayed increase in gait velocity 
may be explained by consciousness and awareness surrounding 
the effort to achieve symmetrical gait, but also by postopera-
tive insecurity in general. van den Akker-Scheek et al. (30) 
let the patients use walking aids at postoperative gait assess-
ment and found increased gait velocity as soon as 6 weeks 
postoperatively. However, in agreement with our findings, 
the largest improvement in gait velocity was seen 6 months 
postoperatively. Self-reported function showed the largest 
overall magnitude of change and ES above 0.58 as soon as 3 
months postoperatively and above 0.61 after 12 months. This 
large and early improvement may be explained by the patients’ 
experience of immediate relief from stiffness and pain, which 
is also previously reported after THR (31). 
The achievement of gait symmetry may be a prerequisite to 
avoid later disease or injury caused by misalignment. Time-
consuming clinically guided exercises, along with muscular 
strengthening and relearning, may be necessary to achieve gait 
symmetry, and naturally lead to improvement later postopera-
tively compared with improvement in self-reported function. 
Our findings support previous findings that highlight the 
importance of including objective measures in postoperative 
evaluation and rehabilitation strategies (8). Self-reported meas-
ures alone, or a failure to also include objective measures with 
unique properties, such as properties suggested for measures of 
ML symmetry in this study, may conceal important functional 
qualities of gait and may also delay rehabilitation after THR. 
The low number of steps per walk may represent a limita-
tion, but is clinically relevant because of limited space avail-
able at typical test locations. However, data were collected 
from 6 walks, with a mean of at least 33 steps at any of the 4 
test occasions (Table I). A number of symmetry indices with 
known limitations have been used previously to quantify gait 
symmetry (32). The two indices used in this study were chosen 
because they relate easily to performance of limbs or move-
ment qualities, and ratio indices are previously advocated for 
similar reasons (33). ES are not calculated from main effect, 
but rather for the preoperative test compared with 12 months 
postoperatively, in addition to neighbouring test occasions, due 
to the limited possibility to calculate ES based on χ2 statistic 
with more than 1 degree of freedom (22). 
Although our results suggest continuous improvement 
throughout the first year following THR in all reported meas-
ures, ML symmetry seems to improve later than the other 
measures evaluated in this study. Longer follow-up periods 
or exercise programmes aimed to strengthen and stabilize the 
trunk and pelvis, and the hip abductors in particular, may reveal 
to what degree the observed change in ML symmetry reflects 
a time-lagged recovery compared with the other measures. 
Future studies should implement disease-specific exercise 
programmes before and after THR, and evaluate change 
over time measured by different objective and self-reported 
clinical outcome measures. Gait symmetry is suggested as a 
preferred measure of gait quality. However, the variation in 
time and magnitude of postoperative change found in this 
study supports the additional inclusion of gait velocity and 
self-reported function to provide a complete postoperative 
evaluation after THR. 
In conclusion, the results of this study showed improve-
ment in gait symmetry, gait velocity and self-reported func-
tion 1 year after THR. Only change in ML symmetry was not 
significant. The magnitude and time of improvement differed 
among clinical outcome measures. Large and early improve-
ment was seen in self-reported function, suggesting immediate 
relief from stiffness and pain post-surgery. Gait symmetry 
and gait velocity showed later improvements, suggesting that 
these functions may require prolonged rehabilitation, with 
muscular strengthening and motor relearning, possibly with 
postoperative guidance. A test-battery including assessment 
of gait symmetry, gait velocity and self-reported function is 
suggested in postoperative evaluation of THR.
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